These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2015-002969-27 A RANDOMISED, SINGLE-BLIND, ACTIVE CONTROLLED, MULTI-CENTRE TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, ACCEPTABILITY AND PALATABILITY OF PMF104 COMPARED TO A CONVENTIONAL PEG-ELECTROLYTE SO... 2021-03-05 due-trials
Reported results Terminated 2017-002258-36 A Phase II, multicentre, double-blind, randomised, placebo-controlled study of Rifaximin delayed release 400 mg tablet: clinical efficacy and safety in the prevention of post-operative endoscopic Croh... 2020-08-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2017-002708-28 Rifaximin delayed release (400 mg tablet) for the prevention of recurrent acute diverticulitis and diverticular complications. A phase II, multicenter, double-blind, placebo-controlled, randomized cli... 2020-12-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2017-003722-33 Safety and Efficacy of Rifaximin Delayed Release 400 mg Tablets in Patients with Moderate-to-Severe Papulopustular Rosacea and Positive Lactulose Breath Test. A Multicenter Double-Blind, Placebo-Contr... 2022-03-21 bad-data
Listed as ongoing, but also has a completion date 2020-000110-15 Multicentre, multinational, randomised, double blind, placebo-controlled study on Sulodexide for the management of leg symptoms in patients with chronic venous disease VEINS (VEnous INvestigation wit... 2022-08-31 bad-data
Listed as ongoing, but also has a completion date 2021-000854-24 Velusetrag for the treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). A multicenter double-blind, placebo-controlled, cross-over, multiple (n=1) trial. Velusetrag para el tratamiento de la ... 2023-04-12 bad-data
Completed, report not yet due Terminated 2021-002311-64 Efficacy and safety of sulodexide in the treatment of chronic primary venous disease of the lower extremities: randomized double-blind placebo-controlled clinical trial Účinnost a bezpečnost sulode... 2023-08-01 not-yet-due